kidney issues with tirzepatide (Zepbound) showed improved function in obese patients both chronic kidney disease and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https Tirzepatide and Kidney Health: Safety

As a result, cost-related issues are slowing the markets growth despite strong clinical demand and efficacy

The findings of this study could provide potential therapeutic materials or target for treating OA

The full safety profile of GLP-1 medications is still under investigation

All PlexusDx medications come from licensed 503A compounding pharmacies, serve all 50 states without insurance, and are HSA/FSA eligible, making protocol changes accessible without membership fees or geographic barriers

Getting personalized guidance and recommendations is key to success

Monitoring considerations include: Blood pressure and heart rate monitoring, with potential adjustment of antihypertensive medications Assessment of electrolytes in patients at risk (those taking diuretics or with significant gastrointestinal symptoms) Targeted cardiovascular assessment based on symptoms and risk factors Gradual dose titration to minimize adverse effects and allow cardiovascular adaptation The CDC recommends that weight loss proceed at 1-2 pounds per week for safety